Back to Trasylol®

An Alabama law firm recently announced that it had filed a lawsuit against Bayer for Trasylol® injuries on behalf of Ada M. Williams. Williams allegedly suffered permanent kidney damage after being given Trasylol® during open heart surgery, which was to prevent excessive bleeding. The personal injury lawsuit was filed Jan. 25, 2007, in the United States District Court for the Middle District of Tennessee, Columbia Division.

The Trasylol® injury lawsuit states that, as a result of being given Trasylol® during open heart surgery, Williams went into kidney failure and now requires kidney dialysis three days a week. Williams is seeking compensation for her pain and suffering and for added medical expenses she continues to incur.

"Ms. Williams is being forced to live the rest of her life with severe and life-threatening kidney problems," says one of her attorneys.

Recently results of a study looking at the long term effects of Trasylol® were published in the Journal of the American Medical Association. The study concluded that Trasylol® showed a 50% increase in the risk of death five years after surgery. The study also estimated that if other medications were used instead of Trasylol®, approximately 2,000 deaths per year might be avoided.

Additionally, a study published in the New England Journal of Medicine revealed that Trasylol® doubled the risk of kidney failure in heart surgery patients. The study also noted that two other drugs that perform the same function as Trasylol® did not increase the risk of kidney failure.

Reference:

"Cory Watson Crowder & DeGaris Files Lawsuit against Pharmaceutical Giant Bayer AG," PRWeb.com, February 2007.